Jul 30, 2026 06:59AM
Jun 26, 2026 07:00AM
May 18, 2026 10:27AM
May 15, 2026 10:14AM
Apr 29, 2026 06:55AM
Apr 29, 2026 06:31AM
Apr 29, 2026 06:30AM Regeneron Reports First Quarter 2026 Financial and Operating Results
Apr 26, 2026 08:00PM
Apr 24, 2026 09:00AM
Jan 30, 2026 01:55PM
Jan 30, 2026 09:03AM
Jan 8, 2026 08:49AM
Jan 7, 2026 10:43AM
Oct 29, 2025 10:25AM Regeneron Pharma (REGN) PT Raised to $740 at Cantor Fitzgerald
Oct 29, 2025 05:12AM
Oct 28, 2025 06:33AM
Oct 27, 2025 07:41AM
Aug 20, 2025 11:19AM
Aug 20, 2025 11:19AM
Aug 14, 2025 03:51AM
Aug 11, 2025 06:00PM Buy this U.S. large-cap biopharma stock: JPMorgan
Aug 1, 2025 07:10AM
Jul 7, 2025 09:45AM
Jul 2, 2025 10:00AM
May 30, 2025 06:37AM
May 27, 2025 08:42AM
May 24, 2025 10:00PM
Apr 29, 2025 06:32AM Regeneron (REGN) Misses Q1 EPS by 26c
Apr 12, 2025 04:00AM
Apr 3, 2025 06:29AM
Mar 10, 2025 01:49PM
Mar 9, 2025 07:32AM
Mar 1, 2025 08:21AM
Feb 25, 2025 06:19PM
Feb 24, 2025 06:18PM ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals
Feb 22, 2025 08:01AM
Feb 18, 2025 07:04PM
Feb 17, 2025 12:03PM
Feb 15, 2025 09:18AM
Feb 13, 2025 01:49PM
Feb 11, 2025 02:28PM
Feb 9, 2025 08:56AM Faruqi & Faruqi Reminds Regeneron Pharmaceuticals Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - REGN
Feb 6, 2025 05:19PM
Feb 6, 2025 04:00PM
Feb 5, 2025 11:51AM
Feb 4, 2025 06:35AM
Feb 4, 2025 05:55AM
Feb 2, 2025 07:46AM
Jan 30, 2025 02:25PM Regeneron Pharmaceuticals (REGN) Faces Securities Class Action After Losing $9 Billion Value Following Q3 2024 Earnings Report- Hagens Berman
Jan 28, 2025 07:36PM

1,214,417 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All